References
- Solheim OP, Seater G, Elomaa I, Alvegarg TA. The treatment of osteosarcoma: present trends. The Scandinavian Sarcoma Group Experience. Ann Oncol 1992; 3: 7–11.
- Picci P, Bacci G, Ruggeri P et al. The treatment of localized osteosarcoma of the extremities: the Italian experience; Studies of the National Research Council. Ann Oncol 1992; 3: 13–17.
- Meyers PA, Heller G, Healey J et al. Chemotherapy for metastatic osteogenic sarcoma: the Memorial Sloan-Kettering Experience. J Clin Oncol 1992; 10: 5–15.
- Link MP, Goorin AM, Horowitz M et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthoped 1991; 270: 8–14.
- Petrilli AS, Gentil FC, Epelman S et al. Increased survival, limb preservation and prognostic factors for osteosarcoma. Cancer 1991; 68: 733–737.
- Bacci G, Picci P, Ruggeri P et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 1990; 65: 2539–2553.
- Morel P, Lapage E, Brice P, et al. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 1992; 10: 1078–1085.
- Strauss DJ, Wong G, Yahalom J et al. Diffuse large cell lymphoma. Prognostic factors with treatment. Leukemia 1991; 5, suppl 1: 32–37.
- Schwartz MK. Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin Chim Acta 1992; 206: 77–82.
- Aul C, Gattermann N, Heyll A et al. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposal for a scoring system. Leukemia 1992; 6: 52–59.
- Sagman U, Feld R, Evans WK et al. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small cell lung cancer. J Clin Oncol 1991; 9: 954–961.
- Von Eyben FE, Blaabjerg O, Madsen EL et al. Serum lactate dehydrogenase isoenzyme 1 and tumor volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumors. Eur J Cancer 1992; 28: 410–415.
- Gerolymatos A, Fotiou S, Tserkezoglou A et al. Evaluation of serum lactate dehydrogenase activity as an index of cervical malignancy. Eur J Gynaecol Oncol 1991; 12: 471–476.
- Kikuchi Y, Hisano A, Kuki E et al. Total lactate dehydrogenase isoenzymes in serum from patients with primary carcinoma of the ovary. Gynecol Obstet Invest 1991; 31: 161–165.
- Nakamura T, Kitagaway F. Anticancer drug screen test with LDH in nude mouse bearing bone and soft sarcoma. Cancer 1985; 56: 1112–1116.
- Furuse K, Masuda S, Yammaki S et al. Cooperative study on limb-salvage for osteosarcoma. Abstact International Symposium in Limb Salvage in Musculoskeletal Oncology Kyoto 1987; 39–40.
- Link M, Shuster JJ, Gorin AM et al. Adjuvant chemotherapy in the treatment of osteosarcoma: results of the multiinstitutional osteosarcoma study. In: Ryan JR and Baker LO: Recent concepts in sarcoma treatment. Kluver Academic Publisher 1988; 283–290.
- Gorin AM, Perez A, Tayde A et al. Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana Faber Cancer Institute Children’s Hospital Study III. J Clin Oncol 1987; 5: 1164–1178.
- Krailo M, Ertel I, Makley J et al. A randomized study comparing highdose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from children cancer study group. Med Ped Oncol 1987; 15: 69–77.
- French Bone Tumor Study Group. Age and dose of chemotherapy as major prognostic factors in trial of adjuvant chemotherapy in osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. Cancer 1988; 61: 1304–1311.
- Thorpe WP, Reilly JJ, Rosemberg SA. Prognostic significance of alkaline phosphate measurament in patients with osteogenic sarcoma receiving chemotherapy. Cancer 1979; 43: 2178–2181.
- Kalifa C, Milika N, Dubousset J et al. The experience of T-10 protocol in the pediatric department of the Goustave Roussy Institute. In: Ryan J and Baker L, Recent concepts in sarcoma treatment. Boston, Kluver 1988: 301–305.
- Winkler K, Beron G, Delling G et al. Neoadjuvant chemotherapy of osteosarcoma. Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6: 329–336.